Investment
Features
FeesSafety
Academy
More
Pluang+

Trimble shifts to software model, sees 54% stock surge potential despite recent price drop

Market News
04 Aug 2026
Andrew Wynn
View Source
Bullish
pluang ai news

Trimble Inc. is transitioning to a software-driven business model to boost predictable, recurring revenue from subscriptions. Despite a recent 20.4% stock price drop, strong Q1 results showed 12% organic revenue growth and 13% growth in Annual Recurring Revenue (ARR). Some analysts remain optimistic, projecting a 54% stock price increase due to the company's attractive valuation and successful shift. This positions Trimble well against competitors and supports a positive long-term outlook.

More News

Bunge Global SA gains insider buy and analyst boost, with price target up 28%

Bunge Global SA gains insider buy and analyst boost, with price target up 28%

Bunge Global SA saw a director purchase 1,500 shares at $107.60, signaling insider confidence. Analysts have set a mean price target of $138.30, implying a 28.3% upside, driven by strong Q2 performance in soybeans and softseeds that raised earnings o...

Market News
Bullish
1 hour ago
Qualys beats Q2 earnings estimates, raises 2026 revenue forecast on cybersecurity growth

Qualys beats Q2 earnings estimates, raises 2026 revenue forecast on cybersecurity growth

Qualys reported strong Q2 2026 results, with earnings per share of $1.98 surpassing the $1.78 consensus and revenue of $182.2 million, an 11% year-over-year increase. The company raised its full-year 2026 revenue guidance to $732-$738 million, reflec...

Company Fundamentals
Bullish
1 hour ago
Stocks plunge amid inverse ETF drops, legal probes, and earnings worries.

Stocks plunge amid inverse ETF drops, legal probes, and earnings worries.

Stocks fell sharply due to various factors including a 58.71% drop in the Defiance Daily Target 2x Short PLTR ETF, driven by strong gains in Palantir Technologies, which the ETF inversely tracks. AdaptHealth shares dropped 38.09% amid a legal investi...

Market News
Bearish
1 hour ago
Law firm probes Karyopharm over executive retention bonuses amid stock price drop

Law firm probes Karyopharm over executive retention bonuses amid stock price drop

Pomerantz LLP is investigating Karyopharm Therapeutics for potential securities fraud related to a retention program granting top executives lump sum cash bonuses between $625,000 and $1,725,000. The announcement led to a 21.45% drop in Karyopharm's ...

Market News
Bearish
1 hour ago
LiveOne to report Q1 Fiscal 2027 results on Aug 12, expecting revenue and EBITDA growth.

LiveOne to report Q1 Fiscal 2027 results on Aug 12, expecting revenue and EBITDA growth.

LiveOne announced it will release its first quarter fiscal 2027 financial results on August 12, 2026, with a conference call to discuss the performance. The company expects continued year-over-year growth in revenue and adjusted EBITDA, driven by org...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App